CAQ-OBGYN common mistakes
CAQ-OBGYN · Understand the traps and how to avoid them.
On a labor curve question with a prolonged second stage, the candidate selects operative vaginal delivery or cesarean without first verifying that the fetal head is at the appropriate station and that complete dilation and adequate descent have been documented, treating the duration of the second stage alone as the trigger for intervention.
Second-stage management is taught as a time-based algorithm, so candidates anchor on the clock and skip the station, position, and estimated fetal weight assessment that determine whether an operative vaginal delivery is even permissible. The exam deliberately supplies a long second stage with a high or unengaged head to see whether the candidate checks prerequisites rather than reacting to the number.
What to do instead
Before answering any second-stage question, write out the four prerequisites for operative vaginal delivery (complete dilation, engaged head at or below a defined station, known position, adequate pelvis with estimated fetal weight compatible) and check each against the stem. If any prerequisite is unmet, the answer is cesarean or continued observation, not forceps or vacuum. Practice by re-reading stems and listing the prerequisites before looking at the options.
When a fetal heart tracing shows recurrent late decelerations, the candidate chooses expectant continued monitoring or a tocolytic as the first step instead of executing the intrauterine resuscitation sequence (maternal repositioning, oxygen, IV fluid bolus, discontinuation of oxytocin, and correction of hypotension) and then escalating if decelerations persist.
Candidates memorize category labels (I, II, III) without internalizing the ordered management algorithm, and they conflate variable decelerations (cord compression, position change first) with late decelerations (uteroplacental insufficiency, improve perfusion and stop oxytocin first). The stem often hides a causative factor such as recent epidural-induced hypotension or tachysystole that must be addressed before deciding on delivery.
What to do instead
Build a one-page decision tree: identify deceleration type, then list the specific resuscitative action for each cause, then state the threshold for operative delivery. For every tracing question, name the cause aloud before selecting management. Review tachysystole and hypotension as reversible triggers, and confirm that the chosen answer addresses the identified cause rather than merely the pattern name.
In a postpartum hemorrhage stem, the candidate jumps to a specific intervention (balloon tamponade, embolization, hysterectomy) without first quantifying blood loss, initiating the massive transfusion or uterotonic escalation protocol, and identifying the cause using the four-T framework (tone, trauma, tissue, thrombin).
Postpartum hemorrhage questions reward sequence knowledge, and candidates who have memorized a list of interventions out of order pick the most dramatic option. The stem frequently provides clues such as a boggy uterus, retained placental fragments, or a coagulation abnormality that point to one cause and therefore one first-line treatment, and missing that clue leads to the wrong branch of the algorithm.
What to do instead
For every hemorrhage question, assign the cause first, then follow the escalation ladder for that cause: uterine massage and uterotonics for tone, exploration and repair for trauma, evacuation for tissue, and product replacement for thrombin. State the resuscitation step (large-bore access, blood products, tranexamic acid where indicated) before any surgical or radiologic option. Drill the order until it is automatic.
On hypertensive disorder questions, the candidate manages blood pressure without addressing magnesium sulfate seizure prophylaxis, or orders magnesium without specifying monitoring parameters, and confuses the treatment threshold for severe-range blood pressure with the threshold for initiating prophylaxis.
Preeclampsia management has several parallel tracks (antihypertensive therapy, seizure prophylaxis, fetal surveillance, timing of delivery) and candidates collapse them into one decision. They also mix up which agent is first-line for acute severe hypertension versus chronic control, and they forget that magnesium dosing requires renal function and reflex monitoring.
What to do instead
Separate the question into four explicit sub-questions: does she need acute antihypertensive therapy, does she need magnesium, what fetal surveillance is indicated, and when should delivery occur by gestational age and severity. Answer each in writing before choosing. Memorize the severe-range threshold and the first-line acute agents, and know the magnesium toxicity monitoring triad (reflexes, respiratory rate, urine output).
When a cervical cancer screening or abnormal cytology result is presented, the candidate recommends colposcopy, repeat cytology, or treatment without correctly applying the age-specific screening start and stop rules, the distinction between screening and diagnostic testing, and the management difference between low-grade and high-grade cytology or between cytology and HPV co-testing strategies.
Cervical screening guidelines have changed repeatedly and differ by age, prior results, and HPV status, so candidates rely on an outdated single algorithm. Stems are constructed so that one detail (age, pregnancy, prior abnormal result, HPV positivity) changes the correct next step, and candidates who do not parse that detail default to colposcopy for everything.
What to do instead
Rebuild the algorithm from first principles: screening start age, screening interval by test modality, exit age, and the management branch for each cytology and HPV combination, noting where pregnancy or immunosuppression changes the path. For each practice stem, highlight the modifying detail before answering. Confirm whether the question asks for the next step in screening or the management of a known abnormality, because the answers differ.
On an abnormal uterine bleeding question, the candidate selects a hormonal or surgical treatment before assigning a PALM-COEIN category, and treats postmenopausal bleeding as benign without confirming that endometrial sampling has been performed and tissue diagnosis obtained.
Abnormal uterine bleeding is presented as a treatment question, so candidates skip the diagnostic classification step. Postmenopausal bleeding is a red-flag presentation in which malignancy must be excluded first, and stems often omit the biopsy result precisely to test whether the candidate orders it before offering therapy.
What to do instead
Adopt a fixed two-step habit: classify the bleeding as structural or nonstructural using PALM-COEIN, then state the diagnostic test required to confirm the category. For any postmenopausal bleeding, the first answer is endometrial sampling (with imaging as an adjunct, not a substitute) before treatment. Only after a benign diagnosis is established should medical or surgical management be selected.
In an adnexal mass or suspected ovarian cancer scenario, the candidate proceeds to surgery or assumes a benign cyst without integrating the risk-of-malignancy assessment, menopausal status, tumor markers, and the role of gynecologic oncology referral and staging, and without recognizing when fertility-sparing surgery is appropriate.
Candidates conflate the workup of a simple cyst with that of a complex mass and do not consistently apply risk stratification tools or the referral threshold to subspecialty care. They also overlook that surgical approach and staging completeness depend on suspected histology and menopausal status, which the stem usually specifies.
What to do instead
For every adnexal mass, state menopausal status, imaging characteristics, and tumor markers first, then decide whether observation, referral, or surgery is indicated. Memorize the features that mandate oncology referral and the situations in which fertility-sparing staging is acceptable. When a stem describes a complex mass with ascites or elevated markers, the answer should reflect referral and staging rather than simple excision.
On an endometrial cancer or postmenopausal bleeding question, the candidate selects a treatment plan without staging the disease or confirming histology, grade, and depth of invasion, and does not distinguish the management of endometrioid from non-endometrioid histology or the indications for lymph node assessment.
Treatment questions look self-contained, but the correct answer depends on stage, grade, and histologic subtype, and candidates answer from a general impression of the disease rather than the specific parameters in the stem. They also miss the influence of molecular classification and the patient's surgical risk on the choice between primary surgery and alternative approaches.
What to do instead
Before answering, extract stage, grade, histology, and surgical candidacy from the stem and write them down. Then map to the standard surgical staging approach and the adjuvant therapy decision. Review the distinction between endometrioid and serous or clear cell tumors and the criteria for omitting lymph node dissection. If the stem lacks a required parameter, the correct answer is usually the diagnostic step that supplies it.
In an infertility evaluation, the candidate orders or interprets tests out of sequence, such as proceeding to ovulation induction or assisted reproduction before confirming tubal patency, ovarian reserve, semen analysis, and uterine cavity assessment, or misinterprets a day-3 hormone panel or anti-Mullerian hormone value as diagnostic of a specific cause rather than as a reserve marker.
Infertility workup is a bundle of tests with defined timing and interpretation, and candidates who memorize the list without the sequence skip the male factor or tubal evaluation. They also overread ovarian reserve markers, treating a low value as an absolute barrier to conception rather than as information that shapes counseling and treatment intensity.
What to do instead
Memorize the core evaluation bundle with its timing: semen analysis, ovulation assessment, tubal patency, uterine cavity evaluation, and ovarian reserve testing, and note that male factor is evaluated early because it is common and cheap to exclude. For each abnormal value, state what it does and does not predict. Practice interpreting reserve markers in context of age and prior response rather than as standalone diagnoses.
On a contraception or hormone therapy question, the candidate recommends a method or regimen without screening for contraindications using the medical eligibility criteria framework, and does not account for the difference between benefits and risks in the context of the patient's age, smoking status, migraine type, thrombosis history, or breastfeeding status.
Candidates remember efficacy rankings but not the eligibility categories, so they recommend combined hormonal contraception to patients with absolute contraindications. They also apply population-level risk data to an individual without weighing baseline risk, which leads to withholding appropriate therapy or recommending an unsafe one.
What to do instead
For every contraception question, list the patient's conditions and check each against the eligibility categories, prioritizing the conditions that make a method an unacceptable risk. Know which conditions prohibit combined hormonal methods versus which require caution. For hormone therapy, frame the answer around indication, age, time since menopause, and route of administration, and state the risk in absolute terms rather than as a general warning.